Pharvaris PHVS
NASDAQ PHVS
$31.71 -0.02 (-0.06%)
As of: Sep 30, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Other Operating Expenses (2021 - 2025)

Updated

Pharvaris (PHVS) posted Other Operating Expenses of $0.00 for Q3 2025.

Analysis

Pharvaris (PHVS) Other Operating Expenses (2021 - 2025) Analysis & Trends

For FY2018, Pharvaris' Other Operating Expenses came in at -$4.31 trillion.

  • The Q3 2025 figure stands as the highest quarterly Other Operating Expenses since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Pharvaris 2.07 Bn -289,124.33 Bn 85,072.10
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2022 0.00
Mar 31, 2022 0.00
Sep 30, 2021 0.00
API Access

Pharvaris Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=PHVS&period=max&api_key=YOUR_API_KEY